今日视点：上市公司“蹭热点”误导投资者行不通、必被罚

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. for allegedly misleading statements related to a strategic cooperation framework agreement signed on January 7, 2026, highlighting the regulatory stance against companies that engage in "hype" to mislead investors [1] Group 1: Impact on Capital Market - The practice of "hype" by listed companies disrupts the principles of transparency and fairness in the capital market, leading to market disorder and misallocation of resources, which undermines the value investment ecosystem and long-term investment philosophy [1] - Companies engaging in "hype" create false positive perceptions through misleading disclosures, which can significantly mislead investors and amplify investment risks, resulting in potential substantial losses when the truth emerges [2] Group 2: Consequences for Companies - Companies may fall into the trap of prioritizing speculation over genuine business operations, risking their credibility and long-term sustainability. A focus on "hype" rather than core business development can lead to market abandonment [3] - Recent cases show that some companies have used voluntary disclosures to engage in "hype," which is prohibited under the newly implemented regulations effective July 1, 2025, that explicitly forbid using voluntary disclosures for market manipulation [3] Group 3: Regulatory Environment - The regulatory authorities are adopting a zero-tolerance approach towards "hype," emphasizing the need for companies to ensure that any information disclosed related to market trends is truthful, accurate, and complete to avoid misleading investors [3] - The development of the capital market relies on a truthful, transparent, and fair environment, which necessitates that companies operate with integrity and focus on value creation [4]